Valuation Report Components
Vanderbilt Health Valuation Lab
September 2, 2022
Components of an Evaluation Report
- Executive Summary
- Company Overview
- Service/Product/Innovation Evaluation
- Intellectual Property and Regulatory Pathway
- Reimbursement/Revenue Pathway
- Impact and Evaluation
- Financial Analysis
- Summary Analysis: Strengths, Weaknesses, Threats and Opportunity (SWOT)
- Recommendation.
Executive Summary
- Brief overview of product/service.
- Identify market gaps.
- How does this company address them?
- What is the size of the addressable market?
- What is the competitive landscape like?
Provide your recommendation.
Executive Summary
Company Introduction
- Provide details on founding, ownership and organization.
- Where is the company now?
Intellectual Property and Regulatory Pathway
Intellectual Property
- What are the key IP components?
- Patents? If so, obtain information on application details, duration, scope, etc.
- Does service/technology require partnership with other firms or services? If so, how is IP protected?
- If service/technology requires integration (e.g., with EHR), how is the company working to ensure seamless integration (and easy plug-ins)?
Regulatory and Policy Landscape
- Who/what are the regulatory & policy stakeholders?
- CMS/HHS?
- FDA?
- State Medicaid agency?
- Other state/federal agencies?
- Are there relevant payment/regulatory changes proposed or under consideration?
Reimbursement/Revenue Pathway
Reimbursement/Revenue Pathway
- What is the current revenue/reimbursement plan?
- How is pricing determined today?
- What is the revenue growth plan?
- Are there are alternative/unexplored revenue/reimbursement strategies?
Impact and Evaluation
- How does the company measure impact?
- To what extent are evaluation and assessments part of the business strategy and operations?
Financial Analysis
SWOT
Strengths |
Weaknesses |
Opportunities |
Threats |
SWOT
Market and Timeline Adjustments